Lakefront Biotherapeutics NV (LKFT) Stock Price, News & Analysis
Company Description
Lakefront Biotherapeutics NV (NASDAQ: LKFT) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $1.8B, ranking #2,370 among all listed U.S. companies by market cap.
This page collects what Stock Titan holds for LKFT, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Lakefront Biotherapeutics NV (LKFT) stock last closed at $28.15. At a market capitalization of $1.8B, LKFT is classified as a small-cap stock with approximately 65.5M shares outstanding.
LKFT Rankings
Latest News
Lakefront Biotherapeutics NV has 1 recent news article. Of the recent coverage, 0 articles coincided with positive price movement and 1 with negative movement. Key topics include acquisition. View all LKFT news →
SEC Filings
Lakefront Biotherapeutics NV has filed 5 recent SEC filings, including 5 Form 6-K. The most recent filing was submitted on July 28, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all LKFT SEC filings →
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Lakefront Biotherapeutics NV (LKFT) currently stands at 2.3 million shares, up 3.8% from the previous reporting period, representing 4.7% of the float. Since May 2026, short interest has increased by 44.9%. This relatively low short interest suggests limited bearish sentiment. With 16.1 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Lakefront Biotherapeutics NV (LKFT) currently stands at 16.1 days. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has increased 72% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 9.4 to 16.1 days.
LKFT Company Profile & Sector Positioning
Lakefront Biotherapeutics NV (LKFT) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ. In monthly performance, the stock ranks #2,660 among all tracked companies.